MarketHub · Chemicals & Materials · Global

Acid Citrate Dextrose Acd Tubes Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The global Acid Citrate Dextrose (ACD) tubes market was valued at approximately $0.606 billion in 2026, representing a one-year growth from the 2025 figure, and is forecast to reach $0.820 billion by 2031 at a compound annual growth rate of 4.5%. Demand is sustained by rising blood donation volumes, increasing chronic disease prevalence, and expanding healthcare infrastructure in emerging economies. ACD tubes remain essential for blood banking, transfusion medicine, and hematology research due to their ability to preserve red blood cell viability during storage and transport.

Market size · 2026
$606 million
CAGR · 2026–2031
4.5%
Forecast · 2031
$755 million
Basis
Claight Analysis
Market size (USD)
Base year 2026
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2026 base: $606M2031 est: $755M
Read the full Acid Citrate Dextrose Acd Tubes Market report →

Market Overview

ACD tubes contain a citrate-based anticoagulant solution that prevents blood clotting while maintaining cell viability during storage and transport, making them essential components in blood banks, hospitals, and diagnostic laboratories worldwide. These tubes are specifically designed for compatibility with automated blood collection systems and are critical for procedures such as whole blood collection, platelet preservation, and hematopoietic stem cell processing. The market encompasses both glass and plastic tube variants across multiple volume capacities, with North America and Europe historically representing the largest demand centers due to established healthcare infrastructure and high transfusion volumes.

Growth Drivers

The expanding global blood donor population and increasing awareness of voluntary blood donation programs have significantly boosted demand for anticoagulant collection tubes. Rising prevalence of trauma cases, surgical procedures, and chronic diseases such as cancer and anemia requiring regular blood transfusions creates sustained demand in hospital and clinical settings. Additionally, growing investment in healthcare infrastructure across Asia-Pacific and Latin America, combined with increased research activities in hematology and immunohematology, are expanding market opportunities.

Want a deeper cut on Acid Citrate Dextrose Acd Tubes Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by product type into ACD Solution A and ACD Solution B tubes, with Solution A commonly used for general blood collection and Solution B preferred for specific preservation applications. Capacity-wise, tubes are categorized into 6.0 mL and 8.5 mL sizes, among other variants, to accommodate different collection protocols. Geographically, North America dominates due to advanced healthcare systems and high per-capita healthcare spending, while Asia-Pacific is expected to witness the fastest growth propelled by improving healthcare access and rising population.

Trends and Outlook

What are the recent trends and outlook?

The market is witnessing a gradual shift toward plastic ACD tubes over glass alternatives, driven by improved safety profiles, reduced breakage risks, and compatibility with modern collection systems.

Talk to a Claight analyst
Do you want to research Acid Citrate Dextrose Acd Tubes Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2026 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.